124 related articles for article (PubMed ID: 31442647)
1. Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
World Neurosurg; 2019 Dec; 132():e613-e617. PubMed ID: 31442647
[TBL] [Abstract][Full Text] [Related]
2. Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; García-Marín V
World Neurosurg; 2019 Jun; 126():e1537-e1541. PubMed ID: 30926559
[TBL] [Abstract][Full Text] [Related]
3. Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients.
Lorente L; Martín MM; Abreu-González P; Ramos L; Cáceres JJ; Argueso M; Solé-Violán J; Jiménez A; García-Marín V
BMC Res Notes; 2019 Dec; 12(1):789. PubMed ID: 31796118
[TBL] [Abstract][Full Text] [Related]
4. Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.
Lorente L; Martín MM; Almeida T; Hernández M; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
Crit Care; 2015 Apr; 19(1):192. PubMed ID: 25928056
[TBL] [Abstract][Full Text] [Related]
5. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.
Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
J Crit Care; 2019 Jun; 51():117-121. PubMed ID: 30802757
[TBL] [Abstract][Full Text] [Related]
6. Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury.
Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Abreu-González P; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Alvarez-Castillo A; Jiménez A; García-Marín V
Neurocrit Care; 2020 Jun; 32(3):790-795. PubMed ID: 31385181
[TBL] [Abstract][Full Text] [Related]
7. Traumatic Brain Injury Patients Mortality and Serum Total Antioxidant Capacity.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Abreu-González P; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32085496
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Serrano N; Rodríguez ST; Jiménez A; Borreguero-León JM
Thromb Res; 2014 Oct; 134(4):832-6. PubMed ID: 25123332
[TBL] [Abstract][Full Text] [Related]
9. Impact of Glasgow Coma Scale score and pupil parameters on mortality rate and outcome in pediatric and adult severe traumatic brain injury: a retrospective, multicenter cohort study.
Emami P; Czorlich P; Fritzsche FS; Westphal M; Rueger JM; Lefering R; Hoffmann M
J Neurosurg; 2017 Mar; 126(3):760-767. PubMed ID: 27035177
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of positive high-sensitivity troponin T in intubated traumatic brain injury patients.
El-Menyar A; Asim M; Latifi R; Bangdiwala SI; Al-Thani H
J Neurosurg; 2018 Dec; 129(6):1541-1549. PubMed ID: 29303440
[TBL] [Abstract][Full Text] [Related]
11. The relationship between serum fibrinogen-like protein 2 concentrations and 30-day mortality of patients with traumatic brain injury.
Chen TJ; Ji MX; Tao ZQ; Fu QY; Xiong K; Cheng B
Clin Chim Acta; 2019 Feb; 489():53-57. PubMed ID: 30503273
[TBL] [Abstract][Full Text] [Related]
12. Estradiol to Androstenedione Ratios Moderate the Relationship between Neurological Injury Severity and Mortality Risk after Severe Traumatic Brain Injury.
Ranganathan P; Kumar RG; Oh BM; Rakholia MV; Berga SL; Wagner AK
J Neurotrauma; 2019 Feb; 36(4):538-547. PubMed ID: 30014751
[TBL] [Abstract][Full Text] [Related]
13. Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.
Rubenstein R; Chang B; Yue JK; Chiu A; Winkler EA; Puccio AM; Diaz-Arrastia R; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Davies P; Agarwal S; Lin F; Sarkis G; Yadikar H; Yang Z; Manley GT; Wang KKW; ; Cooper SR; Dams-O'Connor K; Borrasso AJ; Inoue T; Maas AIR; Menon DK; Schnyer DM; Vassar MJ
JAMA Neurol; 2017 Sep; 74(9):1063-1072. PubMed ID: 28738126
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans.
Zhao YY; Lou L; Yang KC; Wang HB; Xu Y; Lu G; He HY
Clin Chim Acta; 2017 Sep; 472():46-50. PubMed ID: 28732652
[TBL] [Abstract][Full Text] [Related]
15. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
Lorente L; Martín MM; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; Borreguero-León JM
PLoS One; 2015; 10(3):e0121739. PubMed ID: 25822281
[TBL] [Abstract][Full Text] [Related]
17. Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury.
Lorente L; Martín MM; Abreu-González P; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
BMC Neurol; 2017 Jul; 17(1):138. PubMed ID: 28724361
[TBL] [Abstract][Full Text] [Related]
18. Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury.
Lorente L; Martín MM; Almeida T; Abreu-González P; Ramos L; Argueso M; Riaño-Ruiz M; Solé-Violán J; Jiménez A
BMC Neurol; 2015 Jul; 15():115. PubMed ID: 26205136
[TBL] [Abstract][Full Text] [Related]
19. High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.
Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Brain Sci; 2019 Oct; 9(10):. PubMed ID: 31658711
[TBL] [Abstract][Full Text] [Related]
20. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
